What are the guidelines for discontinuing Leuprolide therapy, including tapering strategies and monitoring for withdrawal symptoms or hormonal rebound effects?
Can Leuprolide therapy contribute to weight gain, and what are the underlying mechanisms and lifestyle interventions to prevent or manage this side effect?
How does Leuprolide affect insulin sensitivity and glucose metabolism, and what are the implications for patients with or at risk of developing diabetes?
What are the potential gastrointestinal side effects of Leuprolide, such as nausea, abdominal pain, or changes in appetite, and how can patients alleviate these symptoms?
Can Leuprolide be used in the management of polycystic ovary syndrome (PCOS), and how does it influence symptoms like ovulatory dysfunction, hirsutism, or menstrual irregularities?
Can Novarel administration influence the success rates of assisted hatching procedures, and how does it improve outcomes in embryo transfer cycles?
How does Leuprolide interact with hormonal contraceptives, and what are the recommendations for their concurrent use to manage fertility or hormonal conditions?